Department of Rheumatology, Faculty of Medicine, Saga University, Saga, Japan.
Department of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke, Japan.
Mod Rheumatol. 2024 Oct 15;34(6):1213-1220. doi: 10.1093/mr/roae023.
To define groups and characterize differences in the prognosis of patients with adult-onset Still's disease (AOSD).
We performed a retrospective cohort study. Patients with AOSD were grouped using hierarchical unsupervised cluster analysis according to age, sex, clinical features, and laboratory data. The primary endpoints were overall survival and drug-free remission rate.
A total of 153 patients with AOSD were placed into four clusters. Those in Cluster 1 had a young onset, tended to be female, and had fewer complications and moderate ferritin concentrations. Those in Cluster 2 had a young onset and had more complications and higher ferritin concentrations. Those in Cluster 3 had a young onset, tended to be male, and had no lymphadenopathy and fewer complications. Those in Cluster 4 had an older onset, tended to be female, and had more complications and higher ferritin concentrations. Overall survival tended to be lower (P = .0539) in Cluster 4, and drug-free remission was higher in Clusters 1, 2, and 3 [hazard ratios (HRs) 2.19, 3.37, and 3.62 vs. Cluster 4, respectively].
Four groups of AOSD that have distinct clinical manifestations, ferritin concentrations, severity, and drug-free remission rate were identified, which were lowest in Cluster 4.
定义成人Still 病(AOSD)患者的预后分组,并描述其差异特征。
我们进行了一项回顾性队列研究。根据年龄、性别、临床特征和实验室数据,采用无监督层次聚类分析对 AOSD 患者进行分组。主要终点是总生存率和无药物缓解率。
共纳入 153 例 AOSD 患者,分为 4 组。第 1 组发病年龄较轻,女性居多,并发症较少,铁蛋白浓度中等;第 2 组发病年龄较轻,并发症较多,铁蛋白浓度较高;第 3 组发病年龄较轻,男性居多,无淋巴结肿大,并发症较少;第 4 组发病年龄较大,女性居多,并发症较多,铁蛋白浓度较高。第 4 组总生存率较低(P=0.0539),第 1、2、3 组无药物缓解率较高(与第 4 组相比,风险比分别为 2.19、3.37 和 3.62)。
本研究确定了具有不同临床表现、铁蛋白浓度、严重程度和无药物缓解率的 4 组 AOSD,其中第 4 组最低。